Due to the complexity and rarity of blood disorders, a collaborative effort is required in collecting samples for vital research. PBI collaborates with a large network of national and international partners to establish important disease biobanks. These collaborative networks also conduct research for the standardisation of critical diagnostic assays for rare disease and associated methodologies to expedite disease diagnosis. 

Translational research collaborations

Our Translational Research Team’s current collaboration projects are outlined below.

Project	Partner(s)
Asia-Pacific Microangiopathic Thrombocytopenia Network  (APMAT)	See APMAT for details.
Novel nucleic acid-based biomarkers for thrombotic disorders and in undruggable/difficult to drug cancers	Murdoch University - Centre for Molecular Medicine and Innovative Therapeutics Australian National University
miRNA Regulation of Coagulation Factors	Murdoch University - Centre for Molecular Medicine and Innovative Therapeutics
Anticoagulant Reversal Events Study (ARES)	See ARES for details.
Large Immune Complex and their role in thrombosis	Murdoch University - Centre for Molecular Medicine and Innovative Therapeutics Burnett Institute
Anti-thrombin aptamer	Murdoch University - Centre for Molecular Medicine and Innovative Therapeutics

Our Translational Research Team’s previous collaboration projects are outlined below.

Factor 8 Exon Skipping as a Potential Therapy for Haemophilia A	Murdoch University - Centre for Molecular Medicine and Innovative Therapeutics

Platelet research collaborations

Our Platelet Research Team has a wide network of research collaborators, locally and overseas. These scientists are world experts in their fields, and their contributions are instrumental in our multidisciplinary studies - contributing specialist techniques, knowledge and skills. They are co-investigators on many of our projects, and also co-supervise several higher-degree graduate students (Masters, Honours and PhDs).

The Platelet Research Team’s collaboration projects are outlined below.

Project	Partner(s)
The investigation of pancreatic cancer-derived factors that contribute to cancer-associated thrombosis	Curtin University - School of Pharmacy and Biomedical Sciences
Investigation of Novel Biomarkers for Pancreatic Cancer	Curtin University - School of Pharmacy and Biomedical Sciences
Targeting platelets in pancreatic cancer therapy	Curtin University - School of Pharmacy and Biomedical Sciences
The role of Factor Xa inhibitor and ADAM10 activity on amyloid precursor protein processing in platelet, and dementia risk (co-investigator, Prof Gardiner, ANU)	Curtin University - School of Pharmacy and Biomedical Sciences
Investigating a role for the γ-Secretase enzyme in human derived induced microglia-like cells	Curtin University - School of Pharmacy and Biomedical Sciences
The significance of melanoma-derived exosomes in endothelial dysfunction and metastasis	Curtin University - School of Pharmacy and Biomedical Sciences
Investigating the Functional Role of ORP1-S in Cancer	Curtin University - School of Pharmacy and Biomedical Sciences
Analysis of Neutrophils in the Elderly Environment	Curtin University - Curtin Health Innovation Research Institute
Several platelet-related studies as well as dementia-related projects	Australian National University - John Curtin School of Medical Research
Platelet/cancer studies with a study on platelet/pregnancy in the pipeline	Royal College of Surgeons in Ireland

For more information on PBI research collaborations, please contact our research division.